Antibiotics, Vaccines & Bacterial Therapeutics

Learn about research studies and clinical trials conducted by the Division of Infectious Disease in the areas of antibiotics, vaccines and bacterial therapeutics.

Vaccines and Therapeutics

• Richelle Charles, MD: Human immune responses to cholera and typhoid fever
• Elizabeth Hohmann, MD: Fecal transplantation for C. difficile and other indications
• Cammie Lesser, MD, PhD: Bacterial host-pathogen interactions and the development of designer probiotics as therapeutics
• Gerald Pier, PhD: Virulence and immunity to microbial pathogens
• Mark Poznansky, MD, PhD: Research and development of vaccines and immunotherapies for infectious diseases (including COVID-19 and flu), cancer including HPV induced cancer, Type 1 Diabetes, and neurodegenerative diseases like ALS
• Edward Ryan, MD, DTM&H: Host-pathogen interactions, immune reponses and vaccine development for bacterial pathogens
• Matthew Waldor, MD, PhD: Investigation of pathogen-host interactions in the context of animal models of infection

Antibiotic Resistance and Diagnostics

• Roby Bhattacharyya, MD, PhD: Antimicrobial resistance; microbial genomics and transcriptomics; rapid bacterial and fungal diagnostics; single-cell immune profiling in infection
• Marcia B. Goldberg, MD: Human Signatures for Diagnosis of Bacterial Infection
• Yonatan Grad, MD, PhD: Dynamics of pathogen evolution and spread
• David Hooper, MD: Mechanisms and epidemiology of antimicrobial resistance
• Deborah Hung, MD, PhD: In vivo mechanisms of bacterial pathogenesis and infectious disease diagnostics
• Erica Shenoy, MD, PhD: Optimizing infection control policy to improve patient care and resource allocation